Table 1.
Characteristics of patients with AML, CML and myeloma, Sweden 2002–2009, and proportion with comorbid disease
| AMLa | CMLb | Myeloma | ||||
|---|---|---|---|---|---|---|
| All | CDc | All | CDc | All | CDc | |
| No (%) | No (%) | No (%) | No (%) | No (%) | No (%) | |
| Total | 2550 (100) | 1105 (43) | 1000 (100) | 350 (35) | 4584 (100) | 1735 (38) |
| Median follow up (year) | 0.6 (0.0–11) | 4.2 (0.0–11) | 3.1 (0.0–11) | |||
| Sex | ||||||
| Women | 1262 (50) | 532 (42) | 446 (45) | 155 (35) | 2075 (45) | 745 (36) |
| Men | 1288 (50) | 573 (44) | 554 (55) | 195 (35) | 2509 (55) | 990 (39) |
| Age | ||||||
| 18–49 | 336 (13) | 50 (15) | 210 (21) | 19 (9) | 219 (4.8) | 32 (15) |
| 50–59 | 307 (12) | 82 (27) | 147 (15) | 26 (18) | 605 (13) | 121 (20) |
| 60–69 | 505 (20) | 204 (40) | 208 (21) | 72 (35) | 1145 (25) | 349 (30) |
| 70–79 | 746 (29) | 382 (51) | 242 (24) | 120 (50) | 1499 (33) | 651 (43) |
| 80+ | 656 (26) | 387 (59) | 193 (19) | 113 (59) | 1116 (24) | 582 (52) |
| Median age (range) | 72 (18–100) | 67 (18–99) | 72 (24–97) | |||
| Country of birth | ||||||
| Sweden | 2279 (89) | 996 (44) | 881 (88) | 313 (36) | 4088 (89) | 1553 (38) |
| Outside of Sweden | 271 (11) | 109 (40) | 119 (12) | 37 (31) | 496 (11) | 182 (37) |
| Education level | ||||||
| 0–9 years | 1065 (42) | 533 (50) | 376 (38) | 163 (43) | 1997 (44) | 888 (44) |
| 10–12 years | 958 (38) | 383 (40) | 400 (40) | 122 (31) | 1612 (35) | 557 (35) |
| > 12 years | 464 (18) | 157 (34) | 204 (20) | 57 (28) | 897 (20) | 264 (29) |
| Missing | 63 (2.5) | 32 (51) | 20 (2.0) | 8 (40) | 78 (1.7) | 26 (33) |
| No. of comorbid diseases | ||||||
| 0 | 1445(57) | 650 (65) | 2849 (62) | |||
| 1 | 732 (29) | 225 (22) | 1154 (25) | |||
| 2+ | 373 (15) | 125 (12) | 581 (13) | |||
| Types of comorbid diseases | ||||||
| Cancer | 372 (15) | 134 (13) | 601 (13) | |||
| Cardiovascular disease | 355 (14) | 105 (10) | 510 (11) | |||
| Diabetes | 235 (9.2) | 72 (7.2) | 377 (8.2) | |||
| Cerebrovascular disease | 200 (7.8) | 54 (5.4) | 262 (5.7) | |||
| Chronic pulmonary disease | 148 (5.8) | 51 (5.1) | 243 (5.3) | |||
| Peripheral vascular disease | 77 (3.0) | 30 (3.0) | 97 (2.1) | |||
| Peptic ulcer disease | 51 (2.0) | 30 (3.0) | 110 (2.4) | |||
| Rheumatologic disease | 82 (3.2) | 20 (2.0) | 71 (1.5) | |||
| Renal disease | 22 (0.9) | 5 (0.5) | 55 (1.2) | |||
| Liver disease | 20 (0.8) | 8 (0.8) | 44 (1.0) | |||
| Dementia | 25 (1.0) | 10 (1.0) | 49 (1.1) | |||
| Psychiatric disorders | 29 (1.1) | 16 (1.6) | 73 (1.6) | |||
| Hemiplegia/Paraplegia | 5 (0.2) | 3 (0.3) | 31 (0.7) | |||
| AIDS/HIV | 0 (0.0) | 0 (0.0) | 2 (0.04) | |||
aAML acute myeloid leukemia, bCML chronic myeloid leukemia, cCD comorbid disease